EFFECT OF RANIRESTAT, A NEW ALDOSE REDUCTASE INHIBITOR, ON DIABETIC RETINOPATHY IN SDT RATS

被引：0
|
作者：
Toyoda, Fumihiko [1 ]
Kakehashi, Akihiro [1 ]
Takano, Hiroko [1 ]
Kinoshita, Nozomi [1 ]
Shimmura-Tomita, Machiko [1 ]
Ota, Ayumi [1 ]
Tanaka, Yoshiaki [1 ]
Matsumoto, Takafumi [2 ]
Tsuji, Junichi [2 ]
机构：
[1] Jichi Med Univ, Saitama Med Ctr, Dept Ophthalmol, Saitama, Japan
[2] Dainippon Sumitomo Pharma Co Ltd, Drug Dev Res Labs, Osaka, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
499 diabetic retinopathy; 615; neuroprotection; 554; immunohistochemistry;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1060
引用
收藏
页数：4
相关论文
共 50 条
  • [31] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR, SNK-860, ON DEFICITS IN THE ELECTRORETINOGRAM OF DIABETIC RATS
    HOTTA, N
    KOH, N
    SAKAKIBARA, F
    NAKAMURA, J
    HAMADA, Y
    NARUSE, K
    SASAKI, H
    MIZUNO, K
    MATSUBARA, A
    KAKUTA, H
    FUKASAWA, H
    SAKAMOTO, N
    EXPERIMENTAL PHYSIOLOGY, 1995, 80 (06) : 981 - 989
  • [32] Effect of an Aldose Reductase Inhibitor on Alveolar Bone Loss Associated with Periodontitis in Diabetic Rats
    Kador, Peter F.
    Hamada, Tomofumi
    Reinhardt, Richard A.
    Blessing, Karen
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 138 - 144
  • [33] Aldose Reductase/Polyol Inhibitors for Diabetic Retinopathy
    Obrosova, Irina G.
    Kador, Peter F.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 373 - 385
  • [34] ALDOSE REDUCTASE INHIBITION AND DIABETIC-RETINOPATHY
    HOTTA, N
    KAKUTA, H
    ANDO, F
    MIYAKE, Y
    AWAYA, S
    FUKASAWA, H
    KOH, N
    SAKAMOTO, N
    DIABETES 1988, 1989, 800 : 229 - 232
  • [35] Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats
    Oya, M
    Hosokawa, M
    Tsukada, H
    Fukuda, K
    Nakamura, H
    Tsukiyama, K
    Nagashima, K
    Fujimoto, S
    Yamada, Y
    Semo, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 69 - 77
  • [36] Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients
    Kinekawa, F
    Kubo, F
    Matsuda, K
    Fujita, Y
    Kobayashi, M
    Funakoshi, F
    Uchida, N
    Watanabe, S
    Tomita, T
    Uchida, Y
    Kuriyama, S
    HEPATO-GASTROENTEROLOGY, 2005, 52 (62) : 471 - 474
  • [37] EFFECT OF ALDOSE REDUCTASE INHIBITOR ON RETINOPATHY IN GALACTOSE-FED DOGS
    AKAGI, Y
    KOBAYASHI, T
    TAKAHASHI, Y
    TSUZUKI, S
    KUBO, E
    TAKAYANAGI, K
    MORI, K
    KASAHARA, T
    YONEZAWA, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S172 - S172
  • [38] THE EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON THE CORNEAL ENDOTHELIAL MORPHOLOGY IN DIABETIC RATS
    MATSUDA, M
    AWATA, T
    OHASHI, Y
    INABA, M
    FUKUDA, M
    MANABE, R
    CURRENT EYE RESEARCH, 1987, 6 (02) : 391 - 397
  • [39] ALDOSE REDUCTASE INHIBITOR ZOPOLRESTAT REDUCES HYPERFILTRATION AND ALBUMINURIA IN DIABETIC RATS
    OATES, PJ
    ELLERY, CA
    GOLDFARB, S
    DIABETOLOGIA, 1992, 35 : A148 - A148
  • [40] ALDOSE REDUCTASE INHIBITOR DOES NOT AMELIORATE GLOMERULAR DAMAGE IN DIABETIC RATS
    DANIELS, BS
    HOSTETTER, TH
    CLINICAL RESEARCH, 1988, 36 (03): : A594 - A594
12345